Abstract: A method for forming magnet wire includes co-extruding multiple layers of different insulating materials. A conductor may be provided, and extruded insulation may be formed around the conductor by co-extruding both a first layer of thermoplastic insulation and a second layer of thermoplastic insulation with the second layer formed around the first layer. The first layer may include a first polymeric material having a first thermal index, and the second layer may include a second polymeric material having a second thermal index higher than the first thermal index.

Abstract: Magnet wire including extruded insulation formed from multiple layers of different materials is described. A magnet wire may include a conductor and insulation formed around the conductor. The insulation may include a first layer of extruded thermoplastic insulation formed around the conductor and a second layer of extruded thermoplastic insulation formed around the first layer of extruded thermoplastic insulation. The first layer may be formed from a first polymeric material having a first thermal index, and the second layer may be formed from a second polymeric material having a second thermal index higher than the first thermal index.

Abstract: Magnet wire including extruded insulation formed from multiple layers of different materials is described. A magnet wire may include a conductor and insulation formed around the conductor. The insulation may include a first layer of extruded thermoplastic insulation formed around the conductor and a second layer of extruded thermoplastic insulation formed around the first layer of extruded thermoplastic insulation. The first layer may be formed from a first polymeric material having a first thermal index, and the second layer may be formed from a second polymeric material having a second thermal index higher than the first thermal index.

Abstract: An electronic device and a control method thereof are provided. The control method for the electronic device includes: acquiring a call instruction; calling a target application to acquire collection data; acquiring a security label, in a case that the target application operates in a first operating mode; storing the acquired collection data based on the security label, as a collection data with the security label, wherein the collection data with the security label is in an accessible state when a first access authority is met.

Abstract: Disclosed is an electronic device, including a processor for running a plurality of applications in different security environments; a display unit for displaying the plurality of applications; an input device that operatively initiates an application to be run by the processor; wherein the processor operatively: detects initiation of the application; determines a security level for running the application; selects a security environment from a plurality of security environments based on the determined security level, the security environments providing different security levels; and runs the application in the selected security environment.

Abstract: An electronic device and a control method thereof are provided. The control method for the electronic device includes: acquiring a call instruction; calling a target application to acquire collection data; acquiring a security label, in a case that the target application operates in a first operating mode; storing the acquired collection data based on the security label, as a collection data with the security label, wherein the collection data with the security label is in an accessible state when a first access authority is met.

Abstract: The present invention relates to Glutathione S-transferase (GST)/Reduced Glutathione (GSH) as a means for the in-vivo release of a drug that has been conjugated to specific electrophilic moieties via a sulfonamide bond. The drug may be an anticancer agent (or one with other therapeutic properties) carrying a free —NH— which has been derivatized by the attachment of an electrophile containing a moiety, such as p-CN— or p-NO2-pyridinylsulfonyl groups, or p-NO2- or 2,4 dinitrophenylsulfonyl groups, or suitable derivatives thereof, to make a prodrug. Optionally, the sulfonamide moiety may have attached to it a targeting molecule. The present invention also provides Glutathione S-transferase (GST)/Reduced Glutathione (GSH) as a means for the release of a protected amino derivative that has been conjugated to specific electrophilic moieties via a sulfonamide bond.

Abstract: The present invention relates to Glutathione S-transferase (GST)/Reduced Glutathione (GSH) as a means for the in-vivo release of a drug that has been conjugated to specific electrophilic moieties via a sulfonamide bond. The drug may be an anticancer agent (or one with other therapeutic properties) carrying a free —NH— which has been derivatized by the attachment of an electrophile containing a moiety, such as p-CN— or p-NO 2-pyridinylsulfonyl groups, or p-NO 2- or 2,4 dinitrophenylsulfonyl groups, or suitable derivatives thereof, to make a prodrug. Optionally, the sulfonamide moiety may have attached to it a targeting molecule. The present invention also provides Glutathione S-transferase (GST)/Reduced Gluthathione (GSH) as a means for the release of a protected amino derivative that has been conjugated to specific electrophilic moieties via a sulfonamide bond.